Tenosynovial Giant Cell Tumor research hub

Study of Vimseltinib for Tenosynovial Giant Cell Tumor

This study looks at a new drug, vimseltinib, for a condition called Tenosynovial Giant Cell Tumor (TGCT) when surgery isn't possible. It compares vimseltinib to a dummy drug for 24 weeks, then everyone gets the real drug. It aims to see how well it shrinks tumors.